Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, Ontario, Canada.
Biochem J. 2010 Sep 1;430(2):315-24. doi: 10.1042/BJ20100111.
In its aconitase-inactive form, IRP-1 (iron regulatory protein-1)/cytosolic aconitase binds to the IRE (iron-responsive element) of several mRNAs to effect post-transcriptional regulation. We have shown previously that IRP-1 has ATPase activity and that binding of ATP suppresses the IRP-1/IRE interaction. In the present study, we characterize the binding activity further. Binding is observed with both [alpha-32P]ATP and [alpha-32P]ADP, but not with [gamma-32P]ATP. Recombinant IRP-1 binds approximately two molecules of ATP, and positive co-operativity is observed with a Hill coefficient of 1.67+/-0.36 (EC50=44 microM) commencing at 1 microM ATP. Similar characteristics are observed with both apoprotein and the aconitase form. On binding, ATP is hydrolysed to ADP, and similar binding parameters and co-operativity are seen with ADP, suggesting that ATP hydrolysis is not rate limiting in product formation. The non-hydrolysable analogue AMP-PNP (adenosine 5'-[beta,gamma-imido]triphosphate) does not induce co-operativity. Upon incubation of IRP-1 with increasing concentrations of ATP or ADP, the protein migrates more slowly on agarose gel electrophoresis, and there is a shift in the CD spectrum. In this new state, adenosine nucleotide binding is competed for by other nucleotides (CTP, GTP and AMP-PNP), although ATP and ADP, but not the other nucleotides, partially stabilize the protein against spontaneous loss of aconitase activity when incubated at 37 degrees C. A mutant IRP-1(C437S) lacking aconitase activity shows only one ATP-binding site and lacks co-operativity. It has increased IRE-binding capacity and lower ATPase activity (Km=75+/-17 nmol/min per mg of protein) compared with the wild-type protein (Km=147+/-48 nmol/min per mg of protein). Under normal cellular conditions, it is predicted that ATP/ADP will maintain IRP-1 in a non-IRE-binding state.
在无 aconitase 活性的形式下,IRP-1(铁调节蛋白-1)/胞质 aconitase 与几种 mRNA 的 IRE(铁反应元件)结合,从而实现转录后调节。我们之前已经表明,IRP-1 具有 ATP 酶活性,并且 ATP 的结合抑制了 IRP-1/IRE 相互作用。在本研究中,我们进一步对结合活性进行了表征。观察到与 [alpha-32P]ATP 和 [alpha-32P]ADP 的结合,但与 [gamma-32P]ATP 没有结合。重组 IRP-1 结合约两个分子的 ATP,并且以 1 microM ATP 起始时的 Hill 系数为 1.67+/-0.36(EC50=44 microM)观察到正协同性。apo 蛋白和 aconitase 形式均观察到类似的特征。结合时,ATP 水解为 ADP,并且与 ADP 观察到类似的结合参数和协同性,表明在产物形成中 ATP 水解不是限速步骤。非水解类似物 AMP-PNP(腺苷 5'-[beta,gamma-亚氨基]三磷酸)不会诱导协同性。当将 IRP-1 与递增浓度的 ATP 或 ADP 孵育时,蛋白质在琼脂糖凝胶电泳中迁移得更慢,并且 CD 光谱发生位移。在这种新状态下,核苷酸结合竞争由其他核苷酸(CTP、GTP 和 AMP-PNP),尽管 ATP 和 ADP 但不是其他核苷酸部分稳定蛋白免于在 37°C 孵育时自发丧失 aconitase 活性。缺乏 aconitase 活性的突变体 IRP-1(C437S)仅显示一个 ATP 结合位点,并且缺乏协同性。与野生型蛋白(Km=147+/-48 nmol/min per mg of protein)相比,它具有更高的 IRE 结合能力和更低的 ATP 酶活性(Km=75+/-17 nmol/min per mg of protein)。在正常细胞条件下,预计 ATP/ADP 将使 IRP-1 保持在非 IRE 结合状态。